The Uromigos
A podcast by The Uromigos
401 Episodes
-
Episode 123: Maha Hussain - The Uromigos Legends in GU Cancer series
Published: 20/08/2021 -
Episode 122: Nick Vogelzang - The Uromigos Legends in GU Cancer series
Published: 16/08/2021 -
Episode 121: Conflicts of Interest with the podcasts
Published: 4/08/2021 -
Episode 119: EAU - Surgery in urothelial cancer
Published: 23/07/2021 -
Episode 118: Prostate cancer highlights at EAU
Published: 20/07/2021 -
Episode 117: PD1/VEGF adverse event management in renal cancer
Published: 20/07/2021 -
Episode 116: Renal cancer surgery controversies at EAU
Published: 14/07/2021 -
Episode 112: Genomic classifier of high risk African American men with prostate cancer identifying a high-risk population
Published: 5/07/2021 -
Episode 115: Triplet therapy for 1st line metastatic prostate cancer
Published: 1/07/2021 -
Episode 114: Radionucleotides in prostate cancer
Published: 18/06/2021 -
Episode 113: ASCO 2021 Enazlutamide +/- Radium-223
Published: 18/06/2021 -
Episode 111: The randomised phase 3 CANTATA in metastatic renal cancer
Published: 8/06/2021 -
Episode 110: PEACE1 - Triplet therapy in prostate cancer
Published: 8/06/2021 -
Episode 109: Adjuvant pembrolizumab in renal cancer
Published: 7/06/2021 -
Episode 108: Peter O'Donnell gives five year follow-up data on front line pembrolizumab in urothelial cancer
Published: 7/06/2021 -
Episode 107: ASCO 2021: Neoadjuvant chemo/nivolumab as bladder sparing
Published: 7/06/2021 -
Episode 106: Summary of the three bladder sparing neoadjuvant trials at ASCO 2021
Published: 7/06/2021 -
Episode 105: A Phase 2 study of novel immune combinations (ICOS) in bladder cancer
Published: 7/06/2021 -
Episode 104: Plenary Session 177lu-PSMA-617 in Prostate Cancer
Published: 6/06/2021 -
Episode 103: Targeting the microbiome to increase the activity of immune therapy in renal cancer
Published: 6/06/2021
Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
